S. Jonas and E. Izaurralde, Towards a molecular understanding of microRNA-mediated gene silencing, Nat Rev Genet, vol.16, issue.7, pp.421-454, 2015.

A. Wilczynska and M. Bushell, The complexity of miRNA-mediated repression, Cell Death Differ, vol.22, issue.1, p.4262769, 2015.

C. L. Jopling, M. Yi, A. M. Lancaster, S. M. Lemon, and P. Sarnow, Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA, Science, vol.309, issue.5740, p.16141076, 2005.

C. Esau, S. Davis, S. F. Murray, X. X. Yu, S. K. Pandey et al., miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting, Cell Metab, vol.3, issue.2, p.16459310, 2006.

J. Krutzfeldt, N. Rajewsky, R. Braich, K. G. Rajeev, T. Tuschl et al., Silencing of microRNAs in vivo with 'antagomirs', Nature, vol.438, issue.7068, pp.685-694, 2005.

C. L. Jopling, S. Schutz, and P. Sarnow, Position-dependent function for a tandem microRNA miR-122-binding site located in the hepatitis C virus RNA genome, Cell Host Microbe, vol.4, issue.1, p.3519368, 2008.

E. S. Machlin, P. Sarnow, and S. M. Sagan, Masking the 5' terminal nucleotides of the hepatitis C virus genome by an unconventional microRNA-target RNA complex, Proc Natl Acad Sci, vol.108, issue.8, p.3044371, 2011.

R. K. Jangra, M. Yi, and S. M. Lemon, Regulation of hepatitis C virus translation and infectious virus production by the microRNA miR-122, J Virol, vol.84, issue.13, p.2903297, 2010.

J. Chang, N. E. Marks, D. Sander, C. Lerro, A. Buendia et al., miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1, RNA Biol, vol.1, issue.2, p.17179747, 2004.

R. P. Kincaid, V. L. Lam, R. P. Chirayil, G. Randall, and C. S. Sullivan, RNA triphosphatase DUSP11 enables exonuclease XRN-mediated restriction of hepatitis C virus, Proc Natl Acad Sci, vol.115, issue.32, p.6094126, 2018.

Y. Amador-canizares, A. Bernier, J. A. Wilson, and S. M. Sagan, miR-122 does not impact recognition of the HCV genome by innate sensors of RNA but rather protects the 5' end from the cellular pyrophosphatases, DOM3Z and DUSP11, Nucleic Acids Res, 2018.

Y. Li, T. Masaki, D. Yamane, D. R. Mcgivern, and S. M. Lemon, Competing and noncompeting activities of miR-122 and the 5' exonuclease Xrn1 in regulation of hepatitis C virus replication, Proc Natl Acad Sci U S A, vol.110, issue.5, p.3562843, 2013.

C. D. Sedano and P. Sarnow, Hepatitis C virus subverts liver-specific miR-122 to protect the viral genome from exoribonuclease Xrn2, Cell Host Microbe, vol.16, issue.2, p.4227615, 2014.

J. I. Henke, D. Goergen, J. Zheng, Y. Song, C. G. Schuttler et al., microRNA-122 stimulates translation of hepatitis C virus RNA, EMBO J, vol.27, issue.24, p.2586803, 2008.

A. P. Roberts, A. P. Lewis, and C. L. Jopling, miR-122 activates hepatitis C virus translation by a specialized mechanism requiring particular RNA components, Nucleic Acids Res, vol.39, issue.17, p.3177192, 2011.

P. Schult, H. Roth, R. L. Adams, C. Mas, L. Imbert et al., microRNA-122 amplifies hepatitis C virus translation by shaping the structure of the internal ribosomal entry site, Nat Commun, vol.9, issue.1, p.6031695, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01862144

T. Masaki, K. C. Arend, Y. Li, D. Yamane, D. R. Mcgivern et al., miR-122 stimulates hepatitis C virus RNA synthesis by altering the balance of viral RNAs engaged in replication versus translation, Cell Host Microbe, vol.17, issue.2, p.4326553, 2015.

J. Elmen, M. Lindow, S. Schutz, M. Lawrence, A. Petri et al., LNA-mediated microRNA silencing in non-human primates, Nature, vol.452, issue.7189, p.18368051, 2008.

R. E. Lanford, E. S. Hildebrandt-eriksen, A. Petri, R. Persson, M. Lindow et al., Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection, Science, vol.327, issue.5962, p.3436126, 2010.

S. Ottosen, T. B. Parsley, L. Yang, K. Zeh, L. J. Van-doorn et al., In vitro antiviral activity and preclinical and clinical resistance profile of miravirsen, a novel anti-hepatitis C virus therapeutic targeting the human factor miR-122, Antimicrob Agents Chemother, vol.59, issue.1, pp.599-608, 2015.

/. Aac, 04220-14 PMID: 25385103, p.4291405

M. H. Van-der-ree, J. M. De-vree, F. Stelma, S. Willemse, M. Van-der-valk et al., Safety, tolerability, and antiviral effect of RG-101 in patients with chronic hepatitis C: a phase 1B, double-blind, randomised controlled trial, Lancet, vol.389, issue.16, p.28087069, 2017.

H. L. Janssen, H. W. Reesink, E. J. Lawitz, S. Zeuzem, M. Rodriguez-torres et al., Treatment of HCV infection by targeting microRNA, N Engl J Med, vol.368, issue.18, pp.1685-94, 2013.

T. Shimakami, C. Welsch, D. Yamane, D. R. Mcgivern, M. Yi et al., Protease inhibitor-resistant hepatitis C virus mutants with reduced fitness from impaired production of infectious virus. Gastroenterology, vol.140, p.3155954, 2011.

J. M. Luna, T. K. Scheel, T. Danino, K. S. Shaw, A. Mele et al., Hepatitis C virus RNA functionally sequesters miR-122, Cell, vol.160, issue.6, p.4386883, 2015.
DOI : 10.1016/j.cell.2015.02.025

URL : https://doi.org/10.1016/j.cell.2015.02.025

S. A. Mortimer and J. A. Doudna, Unconventional miR-122 binding stabilizes the HCV genome by forming a trimolecular RNA structure, Nucleic Acids Res, vol.41, issue.7, p.3627571, 2013.

M. Saeed, U. Andreo, H. Y. Chung, C. Espiritu, A. D. Branch et al., SEC14L2 enables pan-genotype HCV replication in cell culture, Nature, vol.524, issue.7566, p.4632207, 2015.

B. Israelow, G. Mullokandov, J. Agudo, M. Sourisseau, A. Bashir et al., Hepatitis C virus genetics affects miR-122 requirements and response to miR-122 inhibitors, Nat Commun, vol.5, p.4236719, 2014.
DOI : 10.1038/ncomms6408

URL : https://www.nature.com/articles/ncomms6408.pdf

S. E. Hopcraft, K. D. Azarm, B. Israelow, N. Leveque, M. C. Schwarz et al., Viral Determinants of miR-122-Independent Hepatitis C Virus Replication. mSphere, vol.1, p.4863629, 2016.

C. Ono, T. Fukuhara, D. Motooka, S. Nakamura, D. Okuzaki et al., Characterization of miR-122-independent propagation of HCV, PLoS Pathog, vol.13, issue.5, p.5441651, 2017.

C. Schuster, C. Isel, I. Imbert, C. Ehresmann, R. Marquet et al., Secondary structure of the 3' terminus of hepatitis C virus minus-strand RNA, J Virol, vol.76, issue.16, p.155128, 2002.

P. Friebe and R. Bartenschlager, Role of RNA structures in genome terminal sequences of the hepatitis C virus for replication and assembly, J Virol, vol.83, issue.22, 2009.

/. Jvi, , p.2772684, 19740989.

U. Nandasoma, C. Mccormick, S. Griffin, and M. Harris, Nucleotide requirements at positions +1 to +4 for the initiation of hepatitis C virus positive-strand RNA synthesis, J Gen Virol, vol.92, p.21270286, 2011.

M. Ramanathan, K. Majzoub, D. S. Rao, P. H. Neela, B. J. Zarnegar et al., RNA-protein interaction detection in living cells, Nat Methods, vol.15, issue.3, p.5886736, 2018.

C. T. Pager, S. Schutz, T. M. Abraham, G. Luo, and P. Sarnow, Modulation of hepatitis C virus RNA abundance and virus release by dispersion of processing bodies and enrichment of stress granules, Virology, vol.435, issue.2, p.23141719, 2013.

P. Central and P. , , p.3534916

J. M. Biegel, E. Henderson, E. M. Cox, G. Bonenfant, R. Netzband et al., Cellular DEAD-box RNA helicase DDX6 modulates interaction of miR-122 with the 5' untranslated region of hepatitis C virus RNA, Virology, vol.507, p.5549679, 2017.

A. Huys, P. A. Thibault, and J. A. Wilson, Modulation of hepatitis C virus RNA accumulation and translation by DDX6 and miR-122 are mediated by separate mechanisms, PLoS One, vol.8, issue.6, p.3691176, 2013.

J. Bruening, L. Lasswitz, P. Banse, S. Kahl, C. Marinach et al., Hepatitis C virus enters liver cells using the CD81 receptor complex proteins calpain-5 and CBLB, PLoS Pathog, vol.14, issue.7, p.6053247, 2018.

L. Zona, J. Lupberger, N. Sidahmed-adrar, C. Thumann, H. J. Harris et al., HRas signal transduction promotes hepatitis C virus cell entry by triggering assembly of the host tetraspanin receptor complex, Cell Host Microbe, vol.13, issue.3, p.23498955, 2013.

B. De-chassey, V. Navratil, L. Tafforeau, M. S. Hiet, A. Aublin-gex et al., Hepatitis C virus infection protein network, Mol Syst Biol, vol.4, p.2600670, 2008.
URL : https://hal.archives-ouvertes.fr/pasteur-00456466

E. S. Svarovskaia, E. Gane, H. Dvory-sobol, R. Martin, B. Doehle et al., L159F and V321A Sofosbuvir-Associated Hepatitis C Virus NS5B Substitutions, J Infect Dis, vol.213, issue.8, pp.1240-1247, 2015.

D. Yamane, D. R. Mcgivern, E. Wauthier, M. Yi, V. J. Madden et al., Regulation of the hepatitis C virus RNA replicase by endogenous lipid peroxidation, Nat Med, vol.20, issue.8, p.4126843, 2014.

J. H. Lumb, Q. Li, L. M. Popov, S. Ding, M. T. Keith et al., Represses Aberrant Activation of Interferon-Stimulated Genes. Cell Rep, vol.20, issue.4, p.5551412, 2017.